Search Results - Edward R. Scheffer Cliff

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Acknowledging Infection Risk in Bispecific Antibody Trials in the Treatment of Multiple Myeloma

    Acknowledging Infection Risk in Bispecific Antibody Trials in the Treatment of Multiple Myeloma by Edward R. Scheffer Cliff, Gemma Reynolds, Rakesh Popat, Benjamin W. Teh, Aaron S. Kesselheim, Ghulam Rehman Mohyuddin

    Published 2023
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  2. 2
    High Cost of Chimeric Antigen Receptor T-Cells: Challenges and Solutions

    High Cost of Chimeric Antigen Receptor T-Cells: Challenges and Solutions by Edward R. Scheffer Cliff, Amar H. Kelkar, David A. Russler‐Germain, Frazer A. Tessema, Adam Raymakers, William B. Feldman, Aaron S. Kesselheim

    Published 2023
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Infections in patients with lymphoma treated with bispecific antibodies: a systematic review and meta-analysis

    Infections in patients with lymphoma treated with bispecific antibodies: a systematic review and meta-analysis by Gemma Reynolds, Marsali Maclean, Edward R. Scheffer Cliff, Benjamin W. Teh, Karin Thursky, Monica A. Slavin, Mary Ann Anderson, Eliza A. Hawkes

    Published 2024
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Infections following bispecific antibodies in myeloma: a systematic review and meta-analysis

    Infections following bispecific antibodies in myeloma: a systematic review and meta-analysis by Gemma Reynolds, Edward R. Scheffer Cliff, Ghulam Rehman Mohyuddin, Rakesh Popat, Shonali Midha, Melissa Ng, Simon J. Harrison, Aaron S. Kesselheim, Benjamin W. Teh

    Published 2023
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    The lucent yet opaque challenge of regulating artificial intelligence in radiology

    The lucent yet opaque challenge of regulating artificial intelligence in radiology by James Hillis, Jacob J. Visser, Edward R. Scheffer Cliff, Kelly van der Geest – Aspers, Bernardo C. Bizzo, Keith J. Dreyer, Jeremias Adams‐Prassl, Katherine P. Andriole

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Non-relapse mortality with bispecific antibodies: A systematic review and meta-analysis in lymphoma and multiple myeloma

    Non-relapse mortality with bispecific antibodies: A systematic review and meta-analysis in lymphoma and multiple myeloma by Tobias Tix, Mohammad Alhomoud, Roni Shouval, Gloria Iacoboni, Edward R. Scheffer Cliff, Doris K. Hansen, Saad Z. Usmani, Gilles Salles, Miguel‐Angel Perales, David M. Cordas dos Santos, Kai Rejeski

    Published 2025
    Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Dietary interventions in cancer: a systematic review of all randomized controlled trials

    Dietary interventions in cancer: a systematic review of all randomized controlled trials by Nosakhare Paul Ilerhunmwuwa, Abul Hasan Shadali Abdul Khader, Calvin Smith, Edward R. Scheffer Cliff, Christopher M. Booth, Evevanne Hottel, Muhammad Aziz, Wade Lee‐Smith, Aaron M. Goodman, Rajshekhar Chakraborty, Ghulam Rehman Mohyuddin

    Published 2024
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy

    A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy by David M. Cordas dos Santos, Tobias Tix, Roni Shouval, Anat Gafter‐Gvili, Jean-Baptiste Alberge, Edward R. Scheffer Cliff, Sebastian Theurich, Michael von Bergwelt‐Baildon, Irene M. Ghobrial, Kai Rejeski, Miguel‐Angel Perales, Kai Rejeski

    Published 2024
    Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition

    Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition by Thomas E. Lew, Victor S. Lin, Edward R. Scheffer Cliff, Piers Blombery, Ella R. Thompson, Sasanka M. Handunnetti, David Westerman, Bryone J. Kuss, Constantine S. Tam, David C.S. Huang, John F. Seymour, Andrew W. Roberts, Mary Ann Anderson

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma

    Sustained remission following finite duration bispecific antibody therapy in patients with relapsed/refractory myeloma by Rajshekhar Chakraborty, Heloise Cheruvalath, Anannya Patwari, Anikó Szabó, Carolina Schinke, Binod Dhakal, Suzanne Lentzsch, Anita D’Souza, Ghulam Rehman Mohyuddin, Kelley Julian, Shonali Midha, Patrick Costello, Martin Kaiser, Melissa Ng, Simon J. Harrison, Edward R. Scheffer Cliff, Meera Mohan

    Published 2024
    Get full text
    Carta
    Save to List
    Saved in:

Search Tools: